Differentiating Grief From Major Depression in a Bereaved Client
A 58-year-old man is referred by his primary care physician eight weeks after his wife died suddenly in a car accident. He reports crying most days, sleeping about four hours a night, a 6 kg weight loss, and difficulty concentrating at work. He says he sometimes hears her voice calling his name when he is falling asleep and momentarily expects her to walk through the door. He denies any wish to die or to harm himself but says life feels 'flat and pointless' and he has stopped seeing friends. He scores 22 on the PHQ-9. He has no prior psychiatric history and drinks two beers most evenings, up from almost none before. He asks whether he is 'going crazy' and whether medication is needed.
1. How would you distinguish normal bereavement from a major depressive episode here, and what in the presentation argues for or against each?
Read the worked answer
The task is differential reasoning, not a checklist. Points supporting uncomplicated grief: the symptoms are temporally tied to the death, the transient sensory experience of hearing her voice at sleep onset is consistent with grief-related hallucinosis rather than a psychotic process, and he has no suicidal ideation, worthlessness, or psychomotor retardation. Points supporting a major depressive episode: symptoms persist past the expected acute period, he meets the duration and symptom-count thresholds (low mood, sleep, appetite/weight, concentration, anhedonia-like withdrawal), and there is functional impairment at work and socially.
The judgment call is that duration alone does not decide it. Grief can meet MDD criteria without being a disorder. What tips the balance is the quality of the symptoms: in grief, dysphoria tends to come in waves triggered by reminders, self-esteem is usually intact, and the 'flat and pointless' quality is more consistent with depression than with pining. The new alcohol use is a risk marker. I would not label it MDD on one visit; I would assess longitudinal course, use a grief-specific measure, and re-evaluate in two to four weeks, watching for persistent anhedonia, global hopelessness, and functional collapse.
2. What is your immediate plan regarding the medication question, safety, and the alcohol use?
Read the worked answer
First, safety: he denies suicidal ideation, but I would ask directly about passive death wish, means access, and protective factors, and document this. His question about 'going crazy' deserves normalizing: hearing a loved one's voice at sleep onset is common in acute grief and is not psychosis.
On medication, I would not promise or refuse it outright. I would explain that grief is not automatically a condition to medicate, that watchful waiting with structured follow-up is reasonable for many people at eight weeks, and that antidepressants are considered when MDD is clearly present, when functioning is severely impaired, or when symptoms persist. Given the weight loss, sleep disruption, and alcohol increase, I would coordinate with his physician rather than work in isolation.
On alcohol, I would explore function (sleep aid? numbing?) without shaming, note that two drinks nightly is above low-risk guidance for many adults, and set a collaborative plan to monitor and reduce, especially if sleep is the driver. I would schedule a follow-up within two weeks, give crisis resources, and involve a support group or trusted family member with his consent.
3. The client says he wants a diagnosis so his employer will grant leave. How do you handle the administrative pressure?
Read the worked answer
I would separate the clinical question from the administrative one. The employer's need for documentation does not change what is clinically accurate. I would ask what the employer actually requires (a diagnosis, a functional statement, or a treating-provider letter) and explain limits of confidentiality and what I will and will not disclose.
If the criteria are met, a diagnosis is appropriate and can be documented; if they are not yet met, I would not inflate a diagnosis to secure benefits. Instead I would describe functional impairment and treatment needs in neutral terms, which is often what leave policies actually require. I would also discuss the risks of a premature label, including its permanence in records and possible stigma, and involve the client in deciding what is shared. If he disagrees, I would document his perspective, offer a second opinion, and explore alternative supports such as employee assistance or short-term disability channels. The ethical anchor is accuracy and informed consent, not advocacy by misrepresentation.